UNH
55
2
AIZ
47
-2
AON
47
-2
HCA
48
-2
AMZN
56
5
MRO
59
-3
MOS
42
2
PVH
57
2
PBI
32
-3
MCD
54
4
GIS
40
3
COP
48
-5
CI
52
7
XYL
33
-4
LRCX
45
2
SWKS
36
3
SWK
64
3
CLX
68
4
PM
60
-8
ED
37
-2
UNH
55
2
AIZ
47
-2
AON
47
-2
HCA
48
-2
AMZN
56
5
MRO
59
-3
MOS
42
2
PVH
57
2
PBI
32
-3
MCD
54
4
GIS
40
3
COP
48
-5
CI
52
7
XYL
33
-4
LRCX
45
2
SWKS
36
3
SWK
64
3
CLX
68
4
PM
60
-8
ED
37
-2
Financhill
Back

Sage Therapeutics Stock Predictions

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
23

SAGE
Sage Therapeutics

Last Price:
5.82
Seasonality Move:
19.95%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Sage Therapeutics Stock Forecast

  • Over the next 52 weeks, Sage Therapeutics has on average historically fallen by 3.6% based on the past 10 years of stock performance.
  • Sage Therapeutics has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Sage Therapeutics Stock Undervalued?
    The current Sage Therapeutics [SAGE] share price is $6.05. The Score for SAGE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • SAGE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Sage Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Sage Therapeutics has on average historically fallen by 3.6% based on the past 10 years of stock performance.

Sage Therapeutics Stock Rating

Sell
23
Sage Therapeutics (SAGE) is a Sell

Is Sage Therapeutics overpriced?

  • Sage Therapeutics has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Sage Therapeutics Stock Price History

Is SAGE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sagerx.com

52-Week Data

52-Week High:
28.26
52-Week Low:
5.84

Prediction Charts

Market Cap:
370.1M
Price in USD:
6.05
Volume:
1.06M
Beta:
1.36

Technical Analysis

SMA50:
7.41
SMA100:
8.93
SMA200:
13.47
52-Wk Change:
-69.29%

Stock Predictions

  • Is Sage Therapeutics stock public?
    Yes, Sage Therapeutics is a publicly traded company.
  • What is the Sage Therapeutics stock quote today?
    The Sage Therapeutics stock price is 6.05 USD today.
  • How to buy Sage Therapeutics stock online?
    You can buy Sage Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-14 6.57 6.81 6.82 6.50
Oct-15 6.87 6.85 7.04 6.82
Oct-16 6.91 7.27 7.30 6.91
Oct-18 7.23 7.57 7.57 7.15
Oct-21 7.55 7.79 7.81 7.41
Oct-22 7.80 7.65 7.83 7.45
Oct-23 7.59 7.65 7.72 7.33
Oct-24 7.68 7.85 7.95 7.57
Oct-25 7.89 8.01 8.16 7.84
Oct-28 8.10 8.54 8.62 8.10
Oct-29 8.53 8.49 8.70 8.34
Oct-30 7.69 6.46 7.97 6.20
Oct-31 6.39 6.09 6.59 5.92
Nov-1 6.09 6.05 6.16 5.84

Sage Therapeutics Earnings

Sage Therapeutics Earnings Report: Per Share Sage Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Sage Therapeutics Forecast Revenue Growth

Sage Therapeutics Stock Analysis: Historical quarterly revenues per share for Sage Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.43 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.15 per share, and an increase next year of $2.10 per share.

* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.